The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Jyotika D Prasad; Annabelle Mahar; Jane Bleasel; Samantha J Ellis; Daniel C Chambers; Fiona Lake; Peter M A Hopkins; Tamera J Corte; Heather Allan; Ian N Glaspole

doi:10.1111/resp.13163

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Respirology. 2017 Oct;22(7):1459-1472. doi: 10.1111/resp.13163. Epub 2017 Sep 10.

Authors

Jyotika D Prasad^{1

2

3}, Annabelle Mahar⁴, Jane Bleasel^{5

6}, Samantha J Ellis⁷, Daniel C Chambers^{8

9}, Fiona Lake^{10

11}, Peter M A Hopkins^{8

9}, Tamera J Corte^{12

13}, Heather Allan¹⁴, Ian N Glaspole^{1

3}

Affiliations

¹ Department of Respiratory and Sleep Medicine, Alfred Hospital, Melbourne, VIC, Australia.
² Department of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
³ Central Clinical School, Monash University, Melbourne, VIC, Australia.
⁴ Pathology Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
⁵ Rheumatology Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
⁶ Sydney Medical Program, University of Sydney, Sydney, NSW, Australia.
⁷ Radiology Department, Alfred Hospital, Melbourne, VIC, Australia.
⁸ School of Medicine, The University of Queensland, Brisbane, QLD, Australia.
⁹ Queensland Lung Transplant Service, Brisbane, QLD, Australia.
¹⁰ Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
¹¹ School of Medicine and Pharmacy, University of Western Australia, Perth, WA, Australia.
¹² Respiratory Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
¹³ Central Clinical School, University of Sydney, Sydney, NSW, Australia.
¹⁴ Lung Foundation Australia, Brisbane, QLD, Australia.

PMID: 28891101
DOI: 10.1111/resp.13163

Abstract

Interstitial lung diseases (ILD) are a diverse group of pulmonary diseases for which accurate diagnosis is critical for optimal treatment outcomes. Diagnosis of ILD can be challenging and a multidisciplinary approach is recommended in international guidelines. The purpose of this position paper is to review the evidence for the use of the multidisciplinary meeting (MDM) in ILD and suggest an approach to its governance and constitution, in an attempt to provide a standard methodology that could be applied across Australia and New Zealand. This position paper is endorsed by the Thoracic Society of Australia and New Zealand (TSANZ) and the Lung Foundation Australia (LFA).

Keywords: clinical respiratory medicine; interstitial lung disease; multidisciplinary meeting; pulmonary fibrosis; rare lung diseases.

MeSH terms

Australia
Evidence-Based Medicine
Guideline Adherence*
Humans
Interdisciplinary Communication
Lung Diseases, Interstitial / diagnosis
Lung Diseases, Interstitial / therapy*
New Zealand
Practice Guidelines as Topic
Pulmonary Medicine*
Societies, Medical*